Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2

Conditions

Metastatic Castration-resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Adenoid Cystic 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × 177Lu-EB-PSMA-617 × Clear all
NCT05170555 2021-12-28

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Peking Union Medical College Hospital

Phase NA Unknown
40 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04801264 2021-03-23

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled

Carcinoma, Adenoid Cystic

NCT03403595 2018-01-18

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Peking Union Medical College Hospital

Phase 1 Unknown
30 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡